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Functional impairments or trafficking defects of inhibitory glycine receptors (GlyRs) have been linked to human hyperekplexia/startle
disease and autism spectrumdisorders.We found that a lack of synaptic integration of GlyRs, together with disrupted receptor function,
is responsible for a lethal startle phenotype in a novel spontaneousmousemutant shaky, caused by amissensemutation, Q177K, located
in the extracellular8–9 loop of the GlyR1 subunit. Recently, structural data provided evidence that the flexibility of the8–9 loop
is crucial for conformational transitions during opening and closing of the ion channel and represents a novel allosteric binding site in
Cys-loop receptors. We identified the underlying neuropathological mechanisms inmale and female shakymice through a combination
of proteinbiochemistry, immunocytochemistry, andboth in vivo and in vitro electrophysiology. Increased expressionof themutantGlyR
1Q177K subunit in vivo was not sufficient to compensate for a decrease in synaptic integration of 1Q177K GlyRs. The remaining
synaptic heteromeric1Q177KGlyRs haddecreased current amplitudeswith significantly faster decay times. This functional disruption
reveals an important role for the GlyR 1 subunit 8–9 loop in initiating rearrangements within the extracellular–transmembrane
GlyR interface and that this structural element is vital for inhibitory GlyR function, signaling, and synaptic clustering.
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Introduction
Glycine receptors (GlyRs) are members of the superfamily of
Cys-loop receptors (CLRs), whose structures have recently been
resolved by x-ray crystallography or cryo-electron microscopy
(EM; Du et al., 2015; Huang et al., 2015). Adult inhibitory GlyRs
form pentameric ion channels with a 2:3 stoichiometry
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Significance Statement
GlyR dysfunction underlies neuromotor deficits in startle disease and autism spectrum disorders. We describe an extracellular
GlyR 1 subunit mutation (Q177K) in a novel mouse startle disease mutant shaky. Structural data suggest that during signal
transduction, large transitionsof the8–9 loopoccur in response toneurotransmitterbinding.Disruptionof the8–9 loopby
theQ177Kmutation results in adisruptionofhydrogenbondsbetweenQ177and the ligand-binding residueR65. Functionally, the
Q177K change resulted in decreased current amplitudes, altered desensitization decay time constants, and reduced GlyR cluster-
ing and synaptic strength. The GlyR8–9 loop is therefore an essential regulator of conformational rearrangements during ion
channel opening and closing.
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(Grudzinska et al., 2005). Disturbances in glycinergic inhibition
are associated with rare disorders such as startle disease (OMIM
149400, hyperekplexia, stiff baby syndrome) and autism spec-
trum disorders (Harvey et al., 2008; Bode and Lynch, 2014; Pi-
lorge et al., 2016). The genetic causes for startle disease have been
defined, with themost common geneGLRA1 (encoding theGlyR
1 subunit) followed by SLC6A5 (glycine transporter 2) and
GLRB (GlyR  subunit; Harvey et al., 2008; Chung et al., 2010;
James et al., 2013). Affected patients show exaggerated startle
responses following unexpected acoustic or tactile stimuli, stiff-
ness in infancy, tremor, and loss of postural control during startle
episodes (Schaefer et al., 2013). GlyRs are important in the spinal
cord for feedback control mechanisms in the nerve–muscle cir-
cuit to balance motoneuron firing and in the brainstem for the
generation of the respiratory rhythm (Bongianni et al., 2010;
Schaefer et al., 2012). The current view of startle disease pathol-
ogy differentiates between functional impairments and biogene-
sis defects (Bode and Lynch, 2014). A recent study (Schaefer et al.,
2015) demonstrated that startle disease mutations also affect
GlyR folding and ER processing, suggesting a higher molecular
complexity of disease mechanisms than was previously assumed.
Due to a similar startle phenotype in mice carrying Glra1
(spasmodic, oscillator) orGlrb (spastic) mutations, mouse models
serve as excellent tools to study the underlying pathological
mechanisms.Oscillator is a functional GlyR 1 subunit null mu-
tation, while spasmodic harbors an A52S missense mutation in
the GlyR 1 subunit (1–2 loop), leading to decreased ligand
affinities but normal life span (Schaefer et al., 2012). The novel
spontaneous mouse mutant shaky carries a missense mutation in
exon 6 of Glra1, resulting in a Q177K substitution in the 8–9
loop of the GlyR1 subunit extracellular domain (ECD). In con-
trast to spasmodic, homozygous shaky mice suffer from serious
neuromotor deficits progressively increasing from postnatal day
14 (P14) until death, indicating that disruption of the 8–9
loop substantially impairs glycinergic function and is incompat-
ible with life.
To date, the 8–9 loop has mainly been investigated by in
vitromutagenesis studies in other CLRs (Thompson et al., 2006;
Hibbs et al., 2009). These studies revealed effects on ligand effi-
cacies or affinities, arguing for an involvement of the8–9 loop
in the ligand-binding process. This view was recently expanded by
the identification of the 8–9 loop forming an allosteric binding
site for the antipsychotic compound chlorpromazine in the closely
related Erwinia ligand-gated ion channel ELIC (Nys et al., 2016).
Structural datahavedemonstrated that the8–9 loop is part of the
signal transduction unit, transferring the closed state upon ligand-
binding into theopenconfigurationandback to theclosed ionchan-
nel state (Du et al., 2015; Morales-Perez et al., 2016). However, the
role of the 8–9 loop in disease mechanisms is unclear.
Here, we found that the 8–9 loop is involved in GlyR syn-
aptic clustering as well as neurotransmitter sensitivity and that a
defect in these mechanisms causes severe startle disease. In neu-
ronal cultures and spinal cord tissue from shaky mice, we ob-
served an increased expression level of GlyR 1Q177K, which was
an unsuccessful attempt at compensation for an observed lack of
GlyR integration into synapses. Decreased agonist efficacy and
faster decay times of 1Q177K GlyRs were recorded in artificial
synapses and ex vivo brainstem slices. Recordings after the onset
of neuromotor symptoms revealed significant reductions in cur-
rent amplitudes, frequencies, and decay times but no changes in
rise times in shaky homozygotes. Thus, shaky represents the first
in vivomodel highlighting that 8–9 loop is a key regulator of
GlyR signaling as it is essential for conformational rearrange-
ments governing both receptor clustering and ion channel gating.
Materials andMethods
Mouse lines.The novelmutantmouse strain shaky arose as a spontaneous
mutation in the animal colony of C. Paige (University Health Network
Research, Toronto, ON, Canada) in a mixed 129X1/SvJ/C57BL/6 strain.
Mice were transferred into the animal facility of the Institute of Clinical
Neurobiology (Wu¨rzburg, Germany), where mice were housed under
pathogen-free conditions; water and food were available ad libitum. All
mice were the offspring of heterozygous /sh matings or crosses with
129X1/SvJ wild-type mice. Experiments were approved by the local vet-
erinary authority (Veterina¨ramt der Stadt Wu¨rzburg) and the Ethics
Committee of Animal Experiments (i.e., Regierung von Unterfranken,
Wu¨rzburg, Germany; license #55.2-2531.01-09/14). Oscillator and
spasmodicmice were a gift fromC.-M. Becker (Institute of Biochemistry,
Friedrich-Alexander University Erlangen-Nu¨rnberg, Erlangen-Nu¨rnberg,
Germany) and derived via embryo transfer into our animal facility. For all
experiments, animals of both sexes were used.
Experimental design and statistical analysis. For each experiment, the
genotype and the sample size are described in the legend of the corre-
sponding figure. Animals of both sexes were used since no significant
differences were detected on the basis of sex, so data were therefore
pooled. Replicates were performed with tissue from different animals or
transfection material from independent transfection rounds, and n val-
ues are always provided in figure legends. Recordings of transfected cells
have been made from at least three independent experiments (except
EC50 values were recorded from one set of experiments). The number of
cells recorded are documented in figure legends. Recordings from slices
were made from at least three independent animals, and the numbers of
cells recorded from how many animals differed are shown in figure leg-
ends. All other experiments have been exhibited at least three times.
Statistical significance was calculated using the one-way ANOVA and the
unpaired t test. The analyses were performed using Origin 6.0 (Microcal
Software), ImageJ version 1.50e software (https://imagej.nih.gov/ij/),
and Graphics Prism Program version 5.0 (GraphPad Software). All p
values are given in the Results section.
Behavioral analysis. The neuromotor phenotype of homozygous
Glra1sh/sh mice was investigated by overall visual examination, hindfeet
clasping, righting ability, assessment of gait by footprint recordings, body
weight, and survival. Videos were recorded with the multi-conditioning
system (256060 series) from TSE. Pictures were taken on P14 and P21,
and body weight was checked over a period of 6 weeks every 2–3 d.
Rotarod. Mice were tested on a motorized rotarod (grooved rod Ø
4 cm; 11-cm-wide compartments; acceleration speed, 2–20 rpm). The
duration of time that mice remained on the rod during rotation was
measured with a maximum of 300 s per animal. Diazepam was injected
intraperitoneally at a concentration of 0.5 mg/kg in a total volume of
100 l of sterile PBS. Control animals were injected with PBS.
RNA isolation and reverse transcription-PCR. RNA extraction from
tissue was performed as recommended by the manufacturer (PEQLAB)
using peqGOLDRNAPure. Onemicrogram of RNAwas used for reverse
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transcription (RT)-PCR. We used RevertAid M-MuLV (Moloney mu-
rine leukemia virus) RT (200U/l) providedwith 5 reaction buffer and
deoxy (d) ATP, dCTP, dGTP, dTTP (10 mM each), and random hexam-
ers (50–200 ng; Thermo Fisher Scientific). Two microliters of cDNA
were used for amplification of the housekeeping gene -actin; GlyR 1,
2, and; gephyrin, andGlyT1 (95°C for 5min; 25 cycles at 95°C for 30 s,
55°C for 30 s, 72°C for 30 s, and 72°C for 10 min).
Cell lines and primary neurons.Human embryonic kidney 293 (HEK293)
cells were grown in minimum essential medium (Thermo Fisher Scien-
tific), supplemented with 10% fetal calf serum, L-glutamine (200 mM),
and 50U/ml penicillin and streptomycin at 37°C and 5%CO2. Cells were
transiently transfected using amodified calciumphosphate precipitation
method. All experiments concerning protein biochemistry withHEK293
cells were performed 48 h after transfection. Primary spinal cord neuro-
nal cultures were prepared at embryonic day 13 (E13). A piece of tail
tissue of each embryo was used for genotyping. Briefly, every spinal cord
was trypsinized using 1 ml of trypsin/EDTA (1 mg/ml) and 10 l of
DNase I (final concentration, 0.1 mg/ml), incubating the suspension at
37°C for 30 min. Trypsinization was stopped with 100 l of fetal calf
serum (final concentration, 10%). After a three-step trituration, the cells
were centrifuged at 300 rpm for 15 min. Trituration was repeated. Cells
were plated on a 3 cm dish with four poly-lysine-covered coverslips and
incubated at 37°C with 5% CO2 at 95% humidity. Spinal cord neurons
were grown in neurobasal medium plus 5 ml of L-glutamine (200 mM)
plus B27 supplement (Thermo Fisher Scientific) with an exchange of
50%medium after 6 d in culture. Neurons older than day in vitro 21were
used for experiments.
Membrane preparations and biotinylation of cell surface proteins. For
membrane protein analysis, crude cell membranes were prepared from
transfected cells or mouse tissue (Sontheimer et al., 1989). Biotinylation
experiments were performed as described previously (Atak et al., 2015).
Radioligand-binding assays. [ 3H]strychnine displacement assays were
performed using filtration assays with triplicates of 80 g of membrane
protein. Samples were incubated for 30min either with 30mM glycine or
buffer B (25 mM potassium phosphate buffer, 200 mM KCl). Then either
glycine or buffer B was replaced by a range of [ 3H]strychnine concentra-
tions (1, 10, 20, 50, 100, and 200 nM; specific activity, 30 Ci/mmol;
DuPont NEN; Kling et al., 1997). Binding data were analyzed by a
nonlinear algorithm provided by the program Origin version 6.0
(Microcal Software).
Western blot and immunostaining. For SDS-PAGE, 11% polyacryl-
amide gels were freshly prepared, followed by Western blot on nitrocel-
lulose membranes (GE Healthcare). Membranes were blocked for 1 h
with 5% BSA in TBS-T (TBS with 1% Tween 20). Primary antibodies
were incubated overnight at 4°C. GlyR proteins were detected with the
pan- antibody for GlyRs (mAb4a; 1:500; catalog #146 011, Synaptic
Systems), GlyR 1 antibody (mAb2b; 1:1500; catalog #146 003, Synaptic
Systems), gephyrin antibody (1:500; catalog #147 003, Synaptic Systems),
-actin (1:5000; catalog #GTX26276, GeneTex), or pan-cadherin (1:
1500; catalog #4068, Cell Signaling Technology) served as a loading con-
trol. Signals were detected using the ECL Plus System (GE Healthcare).
Image quantification forWestern blots was performed using ImageJ ver-
sion 1.50e software (https://imagej.nih.gov/ij/). Data were analyzed us-
ing Student’s t test (ANOVA) or one-way ANOVA, and values below
*p  0.05 were considered significant (**p  0.01, ***p  0.001). The
values are displayed as the mean  SEM or as otherwise noted. The
graphs were generated using Origin version 6.0 software (Microcal
Software).
Immunohistochemistry. Spinal cords were dissected, rapidly frozen on
dry ice, and embedded in Tissue-Tek (Sakura Finetek). Transverse slices
with a thickness of 8–9 m were cut with a cryostat (Jung Frigocut
2800E, Leica). Four to six sliceswere transferred to glass slides (25 75
1.0mm; SuperFrostR Plus,Menzel Gla¨ser/Thermo Scientific) and stored
for further analysis at 80°C. For immunostaining, tissue slides were
fixed for 30 s in ice-cold 2% PFA and immersed once in 50 mM NH4Cl
following quenching for 30 min in 0.1 mM glycine in PBS. Tissue slices
were blocked by 10% normal horse serum in PBS for 1 h at room tem-
perature. The slides were incubated with antibodies GlyR 1 (1:250;
mAb2b; catalog #146 111, Synaptic Systems), VGAT (1:300; catalog #131
003, Synaptic Systems), gephyrin (1:200; catalog #147 003, Synaptic Sys-
tems), and synapsin (1:300; catalog #574778, Calbiochem) in 10% nor-
mal horse serum in PBS overnight at 4°C. After three washing steps with
PBS for 10 min each, tissue was incubated with secondary antibodies
coupled to Cy3 and Alexa Fluor 488 (1:1000, Dianova) diluted in 10%
normal horse serum in PBS for 45 min at 22°C. For staining of the cell
nuclei, slides were incubated in Molecular Probes DAPI solution (Thermo
Fisher Scientific) diluted 1:1500 in PBS for 10min at room temperature in a
dark chamber. Finally, the slides were mounted with aqua polymount
(Polysciences).
Confocal microscopy, and image acquisition and analysis. Images were
acquired using an inverted IX81 microscope equipped with an Olympus
FV1000 confocal laser scanning system, an FVD10 SPD spectral detector,
and diode lasers of 405 nm (DAPI), 495 nm (Alexa Fluor 488), and 550
nm (Cy3). All images shown were acquired with an Olympus UPLSAPO
60 (oil objective; numerical aperture, 1.35) objective. The images were
further developed and organized by Adobe Photoshop CS5 and Illustra-
tor software or Corel Photopaint, Corel Graphic Suite6.
Image analysis for quantification. Single coverslips were acquired using
settings of a photomultiplier identically applied to all samples quantified
in one experiment. Maximal projection images were created from con-
focal stacks usingNIH ImageJ 1.50e software (https://imagej.nih.gov/ij/).
Nonspecific backgroundwas removed using threshold subtraction. In all
experiments, clusters of GlyRs were defined semiautomatically by setting
rectangular regions of interest (ROIs) with dimensions of approximately
8  8 pixels around local intensity maxima in the channel with GlyR
1-specific (mAb2b) staining using OpenView software (Tsuriel et al.,
2006). Mean immunofluorescence (IF) intensities were measured in a
4 4 pixel boxwithin everyROI in all corresponding channels.Obtained
IF intensities were normalized to the mean intensity of control (shaky vs
wild type). All results of IF analysis are shown as the mean  SEM. All
statistical analyses were performed with GraphPad Prism version 5.0
software (GraphPad Software)
Counting of motoneurons.Mice were deeply anesthetized and transcar-
dially perfused as described previously (Jablonka et al., 2000). Slices were
stained with cresyl violet, and motoneurons were counted in every 10th
section of the lumbar spinal cord (L1–L6). The raw countswere corrected
for double counting of split nucleoli as described previously (Masu et al.,
1993). Differences between groups were evaluated with Student’s t test
(unpaired; significance level, *p  0.05), applying the Graphics Prism
Program version 5.0 (GraphPad Software).
Molecular modeling of the GlyR 1 subunit Q177K mutation. The
cryo-EM structure [ElectronMicroscopy Data Bank (EMDB), ID EMD-
6345; Protein Data Bank (PDB), ID 3JAE] of the zebrafish GlyR 1
subunit was used to study the structural and functional effects of the
Q177K substitution. The position of glycine in the binding site wasmod-
eled based on the position of glutamate in the binding site of GluCl (PDB
ID, 3RHW) using a superposition of the two receptors withMODELLER
(Sali and Blundell, 1993). Flexible fitting was performed using
MODELLER/Flex-EM (Topf et al., 2008; Joseph et al., 2016). The non-
synonymous substitution Q177K was modeled into the GlyR using the
swapaa command in Chimera (Pettersen et al., 2004) based on the Dun-
brack backbone-dependent rotamer library (Dunbrack, 2002) and taking
into account the lowest clash score, highest number of H-bonds, and
highest rotamer probability. Flexible fitting resulted in moving R65 into
the EM density.
Electrophysiological recordings from transfected cells. Maximal current
amplitudes (Imax) were measured by patch-clamp recordings in a whole-
cell configuration from transfected HEK293 cells. Current signals were
amplified with an EPC-9 amplifier (HEKA). Whole-cell recordings were
performed by the application of ligand using aU-tube systembathing the
suspended cell in a laminar flow of solution, giving a time resolution for
equilibration of 10–30 ms. Glycine was used at concentrations between
0.3M and 3mM. The external buffer consisted of the following (inmM):
137 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES, pH adjusted to 7.4
with NaOH. The internal buffer consisted of the following (in mM): 120
CsCl, 20 N(Et)4Cl, 1 CaCl2, 2 MgCl2, 11 EGTA, and 10 HEPES, pH
adjusted to 7.2 with CsOH. Recording pipettes were fabricated from
borosilicate capillaries with an open resistance of 4–6 M. Current re-
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sponses were measured at a holding potential of 60 mV. All experi-
ments were performed at 22°C. For desensitization analysis, whole-cell
current traces were transferred to Microcal Origin version 6.0 (Microcal
Software), and the decaying current phase was analyzed using a single
exponential function plus a constant, as shown in Equation 1:
Iobs I1  e
t/1	  Iconst, (1)
where Iobs is the observed total current amplitude, I1 is the fraction of
current desensitizing with time constant 1, and Iconst is the amplitude of
the nondesensitizing current fraction. A single exponential decay plus a
constant termwere sufficient to describe desensitization behavior. Func-
tional constants of the coexpressed subunits were compared using a t test.
A probability of error of *p 0.05was considered significant (**p 0.01,
***p 0.001).
Electrophysiological recordings from artificial synapses. Experiments
were performed as described by Zhang et al. (2015).
Brainstem slice preparation andwhole-cell recordings.Electrophysiolog-
ical experiments were performed on brainstem slices from 18- to 24-d-
old mice. After anesthesia and decapitation, brainstem tissue was rapidly
removed and immersed in ice-cold “high-sucrose” artificial CSF (aCSF)
containing the following (inmM): 75 sucrose, 125NaCl, 3 KCl, 0.3 CaCl2,
7 MgCl2, 1.25 NaH2PO4, 25 NaHCO3, and 30 D-glucose and bubbled
with carbogen (95% O2/5% CO2) at pH 7.4. Transverse slices, 250–350
m thick, containing the PreBo¨tzinger complex (PreBo¨tC) were cut and
transferred into warm (35°C) aCSF for 15min and kept at room temper-
ature thereafter in normal aCSF for at least 1 h before using. Recordings
were performed in normal aCSF buffer, pH 7.4, that contained the fol-
lowing (in mM): 125 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 25
NaHCO3, and 10 D-glucose at 30°C. The brainstem region of interest
was identified based on their location relative to nearby landmarks
such as the inferior olive, hypoglossal nerve and nucleus ambiguus (for
PreBötC). Whole-cell recordings were performed with patch pipettes
filled with an internal solution composed of (inmM): 130 CsCl, 3MgCl2,
5 EGTA, 5HEPES, 2 Na2-ATP, 0.3 Na3-GTP, and 5QX-314, pH 7.3. The
electrode resistance ranged from 3 to 5 M when filled with internal
solution. Whole-cell currents were recorded at a holding potential of
70 mV (corrected for liquid junction potential), filtered (2–6 kHz),
and sampled at 20 kHz using a Multiclamp 700B Amplifier in conjunc-
tion with a Digidata 1440A interface and pClamp10 software (Molecular
Devices).
Constant current pulses (width, 0.01 ms) of 100–400 A were deliv-
ered every 10 s to a bipolar tungsten electrode located in close vicinity
to the preBo¨tC to evoke synaptic responses. Glycinergic IPSCs were
pharmacologically isolated by ionotropic glutamate receptor antagonist
kynurenic acid (KA; 2 mM) and GABAA receptor antagonist bicuculline
methiodide (BMI; 10 M). Glycine (50 M) was used to induce postsyn-
aptic response in the presence of tetrodotoxin (TTX; 1 M) and kynurenic
acid/bicuculline. Strychnine (10M)was applied in some experiments to
verify the glycinergic origin of IPSC or to block glycine-induced currents.
The input–output relationship of evoked IPSCwas plotted with the neg-
ative peaks of synaptic response against the stimulating intensity.
Miniature glycinergic IPSCs (mIPSCs) were pharmacologically iso-
lated by perfusing the slices with aCSF in the presence of KA, BMI, and
TTX. Individual events were detected with Clampfit software (Molecular
Devices) using a template method with amplitude threshold set to 5–6 *
noise. The peak amplitude, 10–90% rise time, 90–10% decay time, and
area were measured and averaged over a minimum of 20 events. For
mIPSCkinetics, only nonoverlapping eventswith relatively fast rise times
(2 ms) and a smooth decay were included in the analysis.
Results
Impairment of GlyR1 subunit8–9 loop underlies a
neuromotor phenotype and lethality in the mouse mutant
shaky
Our current view on startle disease has focused on GlyR variants
that affect either receptor function or biogenesis. However, po-
tential in vivo compensatory mechanisms are still a matter of
debate. Here, we used a novel mouse startle disease model, shaky,
to demonstrate that the extracellular GlyR 1 subunit 8–9
loop is a key structural element for GlyR function, signaling, and
receptor clustering. The combined functional disruption and
synaptic clustering defects in this model allowed us to study the
compensatory mechanisms of both effects in vivo.
The spontaneous mouse mutant shaky became conspicuous
when 
25% of pups at the age of 2 weeks developed a severe
motor defect characterized by typical hindfeet clasping when
picked up by their tails (Fig. 1A), including tremor, muscle
spasms, a twitchy tail, and stiffness. These neuromotor symptoms
are similar to oscillator mice (Buckwalter et al., 1994), a mouse
model of startle disease with a progressive severe phenotype due
to truncated nonfunctional GlyR 1 subunit (Fig. 1A). During
episodes of tremor, shaky mice display a hunched, stiff posture
(Fig. 1A, bottom). The righting ability is poor with a ninefold
increase in righting time between weeks 3 and 4 of life [Glra1/,
0.1  0.1 s; Glra1sh/sh, 32  10 s (*p  0.0351 at P14–P21);
Glra1/, 0.1  0.1 s; Glra1sh/sh 273  68 s (**p  0.00079 at
P22–P28, t test); Fig. 1B]. Homozygous mutant mice are usually
smaller than their littermates and die at 3–6 weeks of age (Fig.
1C). Sequencing ofGlra1 in shakymice (Glra1sh/sh) and littermate
controls revealed two sequence variants: c.T198C in exon 3 (syn-
onymous, p.N38N) and c.C613A in exon 6 (missense, p.Q177K;
numbers refer to mature proteins). The identification of a GlyR
missense mutation provided a plausible explanation for the ob-
served severe motor phenotype similar to other startle disease
mouse models. The synonymous change in exon 3 was not caus-
ative and is a common variant that comes from the hybrid
C57BL/6129SvJ background (rs26948271) of shaky. However,
breeding of heterozygotes for the missense mutation Q177K re-
sulted in an autosomal-recessive inheritance of the mutation fol-
lowing backcrosses from the original mixed background of
C57BL/6129SvJ over 10 generations (614 wild-type animals,
303 heterozygous animals, 138 shaky animals). Sequencing of
other candidate genes affected in startle disease excluded further
pathogenic sequence variations, as only common single nucle-
otide variants were found (Glrb: exon 5, c.A555G, p.L163L,
rs13477223; SLC6A5: exon 2, c.A109G, p.T37A, rs31048165).
To confirm that shaky results from defects in glycinergic
transmission, heterozygous shakymice were bred with heterozy-
gous spasmodic or oscillator mice. Spasmodic carries a different
missense mutation A52S in the GlyR 1 subunit that affects gly-
cine efficacy but results in amild phenotypewith tremor episodes
but normal life span for the animals (Buckwalter et al., 1994; Saul
et al., 1994). Eight matings of shaky and oscillator heterozygotes
generated 10mice with severe motor deficits with onset of symp-
toms at P14 and a life span of 4weeks (Fig. 1D). Genotyping of the
pups exhibited heterozygosity of affected mice for the oscillator
and shaky mutations (Glra1sh/ot), confirming the validity of this
test for allelism. By contrast, heterozygous Glra1spd/sh mice survive
like homozygous Glra1spd/spd mice with similar mild neuromotor
deficits upon tactile or acoustic stimuli (Fig. 1D). Together, these
data provided strong evidence that the pathophysiological mecha-
nism in the spontaneousmousemodel shaky is amissensemutation
(Q177K) inGlra1.
Motor deficits in homozygous shakymice are improved by
benzodiazepine treatment
Due to their impaired motor control, shakymice performed very
poorly on the rotarod test (Glra1/ time on rod, 288  5 s;
Glra1sh/sh time on rod, 15 3 s; ***p 6.935E-27, t test; Fig. 1E).
Humans suffering from startle disease respond to treatment with
benzodiazepines such as clonazepam, which improves symptoms
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by potentiating GABAergic transmission. Therefore, shaky mice
were tested on the rotarod prior to (baseline) and after intraperi-
toneal injection of 0.5 mg/kg diazepam. After this treatment,
shaky mice showed a significant improvement in their perfor-
mance (after diazepam: t 34 7 s;n 10; **p 0.00102, t test)
on the rod (Fig. 1E). Again, improvement of the symptoms fol-
lowing diazepam treatment provides further evidence for a gly-
cinergic transmission defect in shakymice.
ShakyGlyRs have disrupted ligand binding, but the
neuromotor phenotype does not result from disturbed
receptor biogenesis
A first analysis of key proteins at the glycinergic synapse (GlyR
2, GlyR , gephyrin, GlyT1) in wild-type (/), heterozygous
(/sh), and homozygous shaky (sh/sh) mice revealed no obvious
differences at the mRNA level (Fig. 2A). At the protein level (Fig.
2B–E), the distinct expression of GlyR  subunits was detected in
brainstem and spinal cord, but there was only faint expression in
cortex (presumably,2 or3 subunits). Furthermore, specific1
expression was enhanced in spinal cord of Glra1sh/sh (p  0.09,
nonsignificant, t test) and significantly increased in brainstem
(*p  0.019, t test) at P21 when shaky mice exhibit a severe
neuromotor phenotype (Fig. 2B,C). No GlyR 1 expression was
observed in cortex. Gephyrin was also increased concomitantly
with GlyR 1 in the brainstem (*p  0.045, t test) of affected
animals (Glra1sh/sh; Fig. 2B,D). The broad expression of gephyrin
in the cortex is consistent with a major role in GABAA receptor
clustering within this brain area (Tyagarajan and Fritschy, 2014).
A developmental analysis of spinal cord, brainstem, and cortex
from P0 to P28 indicated that GlyR 1 subunit expression in
Glra1sh/sh was indistinguishable from that observed in Glra1/
mice and began at P6 (Fig. 3A). Furthermore, the subunit switch
Figure 1. Shakymice display a neuromotor phenotype and carry a Glra1mutation. A, Comparison of hindfeet and hindlimb clenching behavior of wild-type Glra1/, Glra1sh/sh, and Glra1ot/ot
mice at P14whenmicewere liftedby the tails, andprogressivemotor phenotype at P22 (bottompanels)with rigidity in forelimbs, hindlimbs, and tails.B, Impaired righting timeofmutantGlra1sh/sh
mice. TimeGlra1sh/shmice are required to get up at P14 to P21 comparedwithwild type, prolonged righting time at stage P22 to P28. Cutoff timewas 10min, and 2 of 10mice older than 21 d timed
out. Glra1/, n 7; Glra1sh/sh, n 10. C, Survival curves of Glra1sh/sh, n 9; Glra1/sh, n 19; Glra1/, n 4mice. Glra1sh/shmice die between weeks 3 and 6 of life. D, Survival curves of
backcross experiments with GlyR mutant mouse lines spasmodic (spd) and oscillator (ot): note that heterozygous Glra1sh/ot mice die 4 weeks after birth similar to Glra1ot/ot mice and in contrast to
Glra1/shmice. Glra1sh/spd, n 10; Glra1sh/sh, n 9; Glra1sh/ot, n 10; Glra1ot/ot, n 10. E, Rotarod performance. Wild-type mice had no difficulties staying on the rotating rod for a maximum
time of 300 s. Glra1sh/sh mice were able to remain on the rod for only a few seconds. Glra1/, n 17; Glra1sh/sh, n 12. *p 0.05; **p 0.01; ***p 0.001.
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to increased GlyR 1 levels after birth was completed before the
onset of symptoms at P14. Backcross into the oscillator line re-
vealed a slight but nonsignificant decrease in GlyR 1 protein in
heterozygous Glra1/ot and Glra1sh/ot animals, while the detec-
tion of all GlyR  variants in spinal cord tissue exhibited no
differences among wild-type animals (Glra1/), heterozygous
shaky (Glra1/sh), oscillator (Glra1/ot), and Glra1sh/ot animals
(Fig. 3B,C). Due to theGlra1 frameshiftmutation in the oscillator
line,Glra1ot/ot showed significantly reducedGlyR1 levels (2.5
1.3%) and 40 17%GlyR expression levels corresponding to2,
3, and  subunits (Fig. 3C,D; Kling et al., 1997).
As a functional readout, we examined radioligand binding
using spinal cord tissue from Glra1sh/sh mice compared with
Glra1/ controls. When a saturating concentration of glycine
(30 mM) was replaced by increasing concentrations of [3H]
strychnine (Fig. 2E), a higher strychnine concentration was re-
quired to displace glycine from spinal cord membranes of shaky
mice (Glra1sh/sh, 40 4nM;Glra1/, 14 3nM). AlthoughGlyR
1 expression in shakymice is increased, binding of the antago-
nist strychnine is diminished. To analyze synaptic localization,
we performed immunostaining of spinal cord tissue and samples
from spinal cord cultures from Glra1/ and Glra1sh/sh mice. In
contrast towild-typeGlyR1, a fraction ofGlyR1Q177Kwas not
colocalized with presynaptic markers synapsin and VGAT (Fig.
4A,B) orwith the postsynapticmarker gephyrin (Fig. 4C). Quan-
tification of synaptic GlyR 1 in neuronal cultures demonstrated
a significant decrease in Glra1sh/sh compared with Glra1/
(gephyrin comparison betweenGlra1/ andGlra1sh/sh, p 0.25,
Figure 2. Glra1sh/sh mice display protein expression differences and reduced agonist binding. A, Transcript analysis of GlyR1,2, and subunits, the scaffold protein gephyrin, the glycine
transporter 1 (GlyT1), and -actin (housekeeping gene) in spinal cord, brainstem, and cortex from Glra1/ (marked/), Glra1/sh (/sh), and Glra1sh/sh (sh/sh) mice. B, GlyR protein
expression profile in spinal cord, brainstem, and cortex at P21 in wild-type (/), heterozygous (/sh), and homozygous animals (sh/sh). Gephyrin (geph) was detected at the appropriate
molecular weight of 93 kDa; all GlyR subunits were stained with a pan- antibody (mAb4a, 48 kDa), GlyR1 specifically with mAb2b (48 kDa); and-actin was used as loading control (LC;
42 kDa). C,D, Quantification of GlyR1 protein (C) and gephyrin (D) in spinal cord and brainstemnormalized to-actin inwild-type (Glra1/) and shaky (Glra1sh/sh; n 6–10, *p 0.05, n.s.).
E, Strychnine–glycine competition in spinal cord tissue isolated fromwild-type (pooled,n3) andhomozygous shakymice (pooled,n4), three independentexperimentswereperformed. Thirty
millimolar glycine bound tomembrane preparations of tissuewere displaced by [ 3H]strychnine using increasing concentrations of the radioactive antagonist (0–200 nM). Note the increase in KD in
membrane preparations from shakymice.
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n.s.; GlyR 1 comparison between Glra1/ and Glra1sh/sh, *p
0.018; gephyrin compared with GlyR 1 in Glra1/, p  0.5;
gephyrin comparedwith GlyR1 inGlra1sh/sh, *p 0.017, t test).
An apparent increase in 1Q177K expression observed in shaky
neuronsmay result from an attempt to compensate for the lack of
synaptic 1-containing GlyRs (Fig. 4D,E). Hence, GlyR 1Q177K
expression is enhanced in brainstemand spinal cord, but synaptic
localization is decreased. At the functional level, GlyRs in shaky
mice display a lower strychnine-binding affinity, suggesting an
additive effect of sorting deficits and functional disruption.
The1Q177K mutation impairs the functionality of GlyR
channels in vitro
Using overexpression of GlyRs in transfected HEK293 cells,
quantification of whole-cell and plasma membrane protein of
1Q177K GlyRs was compared with wild-type 1 receptors.
This revealed a significant decrease of 1Q177K surface expres-
sion (heteromeric 1Q177K 33  5% of wild-type 1, **p 
0.003, t test; Fig. 5A). In whole-cell recordings from transfected
cells, it became obvious that 1Q177K cell surface GlyRs could
form functional ion channels with no changes in maximal cur-
rent amplitudes upon 1mMglycine application (Fig. 5B) but with
significantly lower current values at 100 M glycine (1, 4.7
0.3 nA; 1Q177K, 1.13  0.3 nA; ***p  6.616E-06, t test; Fig.
5B). In contrast, on application of 1 mM -alanine or taurine,
1Q177K GlyRs exhibited significantly reduced current ampli-
tudes (-alanine, 3.2  0.3 nA, n  11; compared with 1,
4.5 0.6 nA, n 9; *p 0.033, t test; taurine, 2.8 0.4 nA, n
6; compared with 1, 5.1 0.7 nA, n 5, *p 0.014, t test). A
concentration of 100M for both partial agonists generated again
significantly decreased agonist-induced currents compared with
wild-type receptors (-alanine 1Q177K, 0.23 0.02 nA, n 6;
compared with 1, 1.1  0.2 nA, n  6, **p  0.0014, t test;
taurine, 1Q177K 0.1  0.02 nA, n  6; compared with 1,
0.9 0.09 nA, n 5, ***p 6.72E-06, t test; Fig. 5B).
Hence, the EC50 value for mutated 1
Q177K channels acti-
vated by glycine increased by a factor of 6 (1 EC50  40  6
M; 1Q177K EC50  241  29 M; Fig. 5C). The potencies of
the partial agonists -alanine (1Q177K EC50  318  22 M;
1 EC50 260 50M) and taurine (1
Q177K EC50 389
51 M; 1 EC50 212 34 M) were almost unaffected with a
slight decrease of 1.2- and 1.8-fold, respectively (Fig. 5C).
Desensitization decay time constants were significantly de-
creased for mutant receptors, arguing for faster ion channel clo-
sure of 1Q177K heteromers compared with wild-type channels
(1  1.9 0.14 s; 1Q177K  0.88 0.19 s; *p 0.049,
t test; Fig. 5D). Last, artificial synapses were used to analyze the
1Q177K mutation in the context of spontaneous glycine release
from neighboring spinal cord interneurons. Spontaneous IPSPs
(IPSCs) of 1Q177K compared with 1 exhibited again a sig-
nificant decrease in the decay time constant (***p  5.2066E-5,
t test; Fig. 5E).
Figure 3. Developmental expression of the GlyR1 subunit in shakymice and after backcross into the mouse line oscillator. A, Spinal cord (sc), brainstem (bs), and cortex (cx; negative control)
were analyzed at developmental stages P0, P7, P14, and P28 until severe symptoms in homozygous shakymice comparedwithwild-typemicewere observed. TheGlyR1 subunitwas stainedwith
themonoclonalmAb2bantibodyat 48kDa,with-actinwasusedas a loading control (LC; 42 kDa).1LY represents a lysate control following transfectionofGlyR1 intoHEK293 cells andwasused
as a positive control. B, GlyR expression in P21mouse tissue after backcross of shaky into the oscillator line. Sc, bs, and cx of mice carrying genotypes Glra1/, heterozygous Glra1/sh, Glra1/ot,
Glra1sh/ot, and homozygousGlra1ot/otwere analyzed for the expression of GlyR1 subunit (48 kDa). Note that homozygous oscillatormiceGlra1ot/ot lack1 andGlra1sh/ot aswell asGlra1/ot reveal
reducedGlyR1 levels. Again,-actin served as an LC (42 kDa).C,D, Quantification of GlyR (pan- antibody;C) andGlyR1protein (D) from spinal cord preparations ofGlra1/, heterozygous
Glra1/sh, Glra1/ot, Glra1sh/ot animals, and homozygous oscillator Glra1ot/ot normalized to-actin. The expression level of wild-type animals Glra1/were set to 1 (100%), n 4, *p 0.05.
n.s. nonsignificant.
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Themutation Q177K disrupts GlyR function by faster ion
channel closure
To investigate glycinergic synaptic signaling in intact synapses in
situ, we prepared brainstem slices fromwild-type and shakymice
and performed whole-cell recordings from neurons of the Pre-
Bo¨tC, a nucleus rich in GlyR 1 expression and important for
respiration. When strychnine-sensitive glycinergic IPSCs (Fig.
6A) were evoked at different stimulus intensities in PreBo¨tC neu-
rons at P18 to P24, a dramatically flattened input–output rela-
tionship in the mutant preparation was obtained (***p  0.001
for all stimulus intensities; for values see the legend of Fig. 6B).
Bath-applied glycine (50 M) caused a significant smaller base-
line shift inGlra1sh/sh neurons compared with control, again sug-
gesting a deficit in postsynaptic GlyR function (***p 0.0004, t
test; Fig. 6C). mIPSC recordings (in 1 M TTX) from PreBo¨tC
neurons to study individual glycinergic synapses revealed signif-
icantly lower frequency, smaller amplitudes, and accelerated de-
cay in Glra1sh/sh neurons (mIPSCs: Glra1/ compared with
Glra1sh/sh, amplitude *p  0.032; frequency, *p  0.031; decay,
**p 0.0017; rise time, p 0.423, nonsignificant). These effects
were independent from the block of spontaneous spiking by TTX
(spIPSCs;Glra1/ compared withGlra1sh/sh: amplitude, ***p
4.27E-06; frequency, ***p  2.55E-07; decay, ***p  2.58E-06;
rise time, p 0.211, nonsignificant; Fig. 6D,E).
Many PreBo¨tC neurons receivemixedGABAergic/glycinergic
inhibitory synaptic input with a corelease of both neurotransmit-
ters from the same synaptic terminal (Rosenmund and Stevens,
1996). GABAergic spIPSCs, however, did not differ in frequency
between the genotypes (p 0.067, nonsignificant; Fig. 7), argu-
ing against a generalized reduction in inhibitory synaptic termi-
nal number or release probability as the main factor behind
defects in glycinergic inhibition. To further exclude an overall
decrease in motoneuron number as a modifier of the underlying
pathology in shaky mice, the number of motoneurons was
counted in lumbar spinal cord. No differences betweenGlra1/
and homozygousGlra1sh/sh animals were observed in six to seven
Figure 4. GlyR1 Q177K results in a lack of synaptic integration. A–C, Immunohistological stainings of spinal cord tissue from Glra1/ compared with homozygous Glra1sh/sh animals. Spinal
cord slides (9 m) were stained for the GlyR 1 subunit with the monoclonal antibody mAb2b together with presynaptic markers synapsin (syn; A) vesicular transporter (VGAT; B) and the
postsynapticmarker gephyrin (geph; C). Ventral or dorsal horns aremarked by awhite dotted line. DAPI was used to stain nuclei. Right panels represent enlarged images of each staining. Note that
there is less colocalization of GlyR 1 and gephyrin in homozygous shaky mice (white arrows). D, Spinal cord neuronal cultures from E13 embryos with genotypes Glra1/ or Glra1sh/sh were
differentiated for 3weeks in culture and stained for1 (mAb2a) and gephyrin. An upregulation of GlyR1 in shaky neuronswas observed, but less colocalization in synaptic clusters with gephyrin
(white arrows). Right panels represent enlarged dendrites of spinal cord neurons, which aremarked by white boxes. E, Quantification of synaptic clusters in neurons from Glra1/ and Glra1sh/sh,
n11 fromtwo independent experiments. The relative expressionof gephyrin andGlyR1 is shown (*p0.05, n.s.), comparisonof expression levels betweenGlra1/andGlra1sh/shandwithin
each group.
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animals analyzed for each genotype (p  0.44, nonsignificant, t
test; Fig. 8A, B). To conclude, the dramatically decreased ampli-
tudes in glycine-evoked currents, mIPSCs, and spIPSCs explain
the severity of the observed shaky phenotype. Similar to record-
ings from overexpressed cells as well as artificial synapses, decay
times were accelerated in brainstem slice recordings, suggesting a
function of the GlyR 8–9 loop in the glycinergic signal trans-
duction pathway.
Q177K disrupts hydrogen bonding with residues in the
ligand-binding pocket
The recently uncovered cryo-EM structure of zebrafish GlyR 1
(PDB ID, 3JAE) provided evidence that the 8–9 loop harbor-
ing the Q177K mutation is involved in ion channel opening/
closing processes (Du et al., 2015). Glycine was modeled into the
GlyR structure based on the position of glutamate in the binding
pocket of GluCl (Hibbs and Gouaux, 2011) by superposition of
GluCl (PDB ID, 3RHW) onto the GlyR structure. The Q177K
substitution was inserted into the glycine-bound open-channel
state as part of -strand 9 (Fig. 9A–C). The glycine-binding
pocket comprises residues R65 and S129 from one subunit (B)
and F159, Y202, T204, and F207 from the adjacent subunit (A;
Fig. 9C). R65 is crucial for ligand binding as it interacts with the
-carboxyl and -amino groups of glycine (Grudzinska et al.,
2005). The guanidinium group of R65 has an electrostatic inter-
actionwith the glycine carboxylate group (in the pocket), but also
forms an additional H-bond with the Q177 side chain (Fig. 9D).
The Q177K substitution is predicted to not only abolish the for-
mation of the H-bond between Q177 and R65 but is also likely to
alter the position of R65 side-chain due to the additional positive
charge contributed by the lysine side-chain. This in turn could
lead to destabilization of the glycine-binding pocket (Fig. 9E). In
Figure 5. GlyR1 Q177K leads to reduced agonist potency and faster decay times. A, Expression of wild-type andmutant heteromeric receptor complexes following cotransfection with the GlyR
 subunit in HEK293 cells. Biotinylation assays were used to discriminate between surface andwhole-cell protein. Left, Quantification of wild-type andmutant GlyR1 proteinwith or without the
GlyR-subunit fromwhole-cell and surface pools normalized to pan-cadherin; data were obtained from at least three independent sets of experiments (n 3–6). Right, Western blot analysis of
biotinylation assays. The monoclonal pan- antibody was used for recognition of the GlyR1 subunit (48 kDa), the membrane protein pan-cadherin served as a loading control (LC; 135 kDa). UT,
Untransfected cells;MOCK, GFP-transfected cells.B, Functional parameters fromwhole-cell recordings of transfectedHEK293 cells for1 and1 Q177Kheteromeric receptor configurations,with
current amplitudes at 1mM (1, n 9;1 Q177K, n 16) and 100M glycine (1, n 5;1 Q177K, n 5); 1mM (1, n 11;1 Q177K, n 9) and 100M-alanine (1, n 6;
1 Q177K, n 6); and 1mM (1, n 6;1 Q177K, n 5) and 100M taurine (1, n 5;1 Q177K, n 6). C, Ligand-binding potencies (EC50) determined by current measurements of
transfected cells expressing the heteromeric receptor configurations1 and1 Q177K according to the adult in vivo receptor configuration at seven different glycine,-alanine, and taurine
concentrations (0.3–3.000M,n5 for each receptor configurationand for theagonist used). The1mMconcentrationof theagonist glycineor thepartial agonists-alanineand taurinewereused
to determine Imax values.D, Decay times for desensitization. The decay currentswere calculated in the presence of agonist (1 s). Right, Representative scaled current traceswith1 (n 5, black)
and1 Q177K (n 6, red). E, Faster decay of shaky channels expressed in artificial synapses. Spontaneous IPSCs of1 (black) and1 Q177K (red) shown at two different time scales, 20 s and
100 ms. Quantification of decay time constants of1 (n 10) and1 Q177K (n 9) in artificial synapses/ enlarged scaled view of1 (black) and1 Q177K (red). p 0.05; **p 0.01;
***p 0.001.
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summary, disrupted hydrogen bonding affecting key ligand-
binding residues is likely to underlie the functional impairment
shown by biochemical and physiological approaches and ex-
plains the severity of the shaky phenotype.
Discussion
Our results comprehensively illustrate the importance of the
8–9 loop structure within the extracellular domain for GlyR
ligand binding and the subsequent conformational changes en-
abling signal transduction and synaptic clustering. The current
understanding of GlyR ion channel function suggests the cou-
pling of movements within the ECD (loop C, 1–2, 6–7)
upon ligand binding proceeding to elements of the ECD–trans-
membrane domain interface (10–pre-M1, the M2–M3 loop).
These conformational rearrangements result in tilting of trans-
membrane domains, enabling ion channel opening and closing
(Hassaine et al., 2014; Du et al., 2015; Gielen et al., 2015;Huang et
al., 2015). The role of the 8–9 loop, a flexible region localized
at the complementary side of adjacent subunits underneath the
ligand-binding pocket, has remained elusive due to the overall
low electron density observed for this unstructured region of the
ligand-binding site in earlier studies (Brejc et al., 2001; Hansen et
al., 2005). Here, using the shaky mutant mouse that harbors a
8–9 loop alteration, we found in vivo evidence that this extra-
cellular loop is involved in stabilizing the GlyR ligand-binding
site and ion channel gating. The pathogenic mechanism in this
mouse mutant delineates a combined pattern of biogenesis de-
fects resulting in defective synaptic integration, together with
lower opening frequency, smaller amplitudes, and accelerated
decay rates for remaining GlyRs, functional disturbances that are
incompatible with survival.
Figure6. Shakymicehave impairedglycinergic synaptic transmission inPreBo¨tCneurons.All recordingsweremade inwhole-cell voltage-clampmode in thepresenceof the ionotropicglutamate
receptor antagonist KA (2mM) and the GABAA receptor antagonist bicuculline (10M). A, Traces from awild-type PreBo¨tC neuron illustrate the evoked IPSC (at stimulation intensity of 200A for
0.1ms) and sensitivity to strychnine (10M).B, Input– output curves of evoked IPSCs in Glra1/ (n 24 from 12mice) and Glra1sh/sh (n 25 from 12mice)mice; comparison of Glra1/ and
Glra1sh/sh at 100A: ***p 3.198E-09; at 200A, ***p 1.539E-12; at 300A, ***p 3.20E-12; at 400A, ***p 3.32E-12, t test). C, Traces fromwild-type and Glra1sh/sh neurons show
postsynaptic current responses to glycine application (50M), recorded in TTX (1M). Note the increase in baseline noise with glycine in Glra1sh/sh neuron, despite no shift in the holding current.
Diagramon the right summarizes glycine-induced currents (Glra1/, n 7 from3mice;Glra1sh/sh, n 9 from4mice).D, Traces of spontaneously occurringmIPSCs, recorded in TTX (1M) from
both genotypes, illustrate the reduced action potential-independent synaptic activity in Glra1sh/shmice. AveragedmIPSCs from the two neurons were superimposed and normalized, revealing the
strong decrease in amplitude and acceleration in decay for Glra1sh/sh mIPSCs. E, Quantitative analysis of spIPSCs (without TTX) and mIPSCs in PreBo¨tC neurons demonstrates significant changes in
properties and kinetics of spontaneously occurring events (spIPSCs: Glra1/, n 17 from 10mice; Glra1sh/sh, n 21 from 12mice;mIPSCs: Glra1/, n 6 from 3mice; Glra1sh/sh, n 6 from
4mice). *p 0.05; **p 0.01; ***p 0.001.
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In humans and rodents, mutations in GlyR subunit genes are
associated with startle disease, characterized by exaggerated re-
sponses to acoustic stimuli and uncontrolled falling (Bode and
Lynch, 2014) with an increased risk of cognitive deficits, such as
learning difficulties or delay in speech acquisition (Thomas et al.,
2013). The phenotype of the shaky mouse is in line with that of
human patients, as well as strychnine poisoning (Buckwalter et
al., 1994) and with other glycinergic mouse models (e.g., spastic,
oscillator, and Nmf11; Traka et al., 2006; Schaefer et al., 2012).
Our in vitro analysis revealed differences in surface expression
between heteromeric wild-type 1 and mutant 1Q177K
GlyRs. Mutant 1Q177KGlyRs were able to form functional ion
channels with increased EC50 values. However, the desensitiza-
tion time constant decreased for 1Q177K GlyRs, indicating
faster ion channel closure. The observed changes in vitro pro-
vided some explanations for the glycinergic defect present in vivo;
however, the lethality of homozygous shaky mice presented a
conundrum. A fivefold to sixfold reduction of GlyR agonist po-
tency has also been documented in spasmodic mice carrying an
A52S substitution in the 1–2 loop of the GlyR 1 subunit
ECD. In contrast to shaky mice, homozygous spasmodic mice
display a normal life span and a mild neuromotor phenotype,
arguing that the shift in agonist potency alone cannot explain
lethality (Graham et al., 2011). Moreover, in vivo expression
levels of 1Q177K were increased in spinal cord and brainstem,
although synaptic integration was significantly diminished. Syn-
aptic integration of GlyRs is enabled by the scaffolding protein
gephyrin via high-affinity binding to the intracellular M3–M4
domain of the GlyR  subunit (Triller and Choquet, 2005; Du-
moulin et al., 2010). A consequence of lower synaptic integration
is less synaptic strength, which is normally regulated by lateral
diffusion of synaptic and extrasynaptic receptors in and out of
synapses (Triller and Choquet, 2005). The lower number of syn-
aptic complexes argues that the extracellular binding site muta-
tion is able to transduce conformational changes to the M3–M4
loop domain, thereby disrupting gephyrin binding and, thus,
synaptic anchoring of 1Q177K GlyRs. In turn, these data sug-
gest that glycine sensitivity or gating properties of the receptor
can be altered by the clustering status of the GlyR at the synapse.
Another option that may explain the reduced synaptic integra-
tion is an enhanced turnover of the synaptic receptor pool via
endocytosis as a neuronal adaptation to the impaired functional-
ity of 1Q177K GlyRs in vivo. We therefore conclude that the
enhanced expression of 1Q177K represents an unsuccessful at-
tempt at neuronal compensation.
In addition to the postsynaptic effects of the shakymutation,
there may also be presynaptic consequences for functionally
impaired homomeric1Q177K GlyRs. A potential role for presyn-
aptic homomeric GlyRs in hyperekplexia has recently been dem-
onstrated (Xiong et al., 2014). Presynaptic GlyR 1 subunit
homomers have been described in calyceal synapses in themedial
nucleus of the trapezoid body, in spinal cord and the ventral
tegmental area (Turecek and Trussell, 2001; Jeong et al., 2003).
Activation of these presynaptic GlyRs by glycine spillover triggers
weakly depolarizing Cl currents. The generated depolarization
leads to enhanced transmitter release by Ca2 channel activation
and increased Ca2 concentrations in the nerve terminal (Ture-
cek and Trussell, 2001). The increase in 1Q177K expression in
vivomay result in an enhanced expression of presynaptic homo-
meric GlyRs generating impaired presynaptic GlyR activity and
thus, diminished glycine release in the brainstem and spinal cord
of shaky mice. Consequently, disrupted presynaptic GlyR func-
Figure 7. The shaky mutation does not affect GABAergic synaptic transmission in the Pre-
Bo¨tC neurons. All recordings weremade in the presence of KA (2mM). The frequency of GABAe-
rgic spIPSCs was calculated by comparing and subtracting the spIPSCs before and after
bicuculline (10M) application in the same neuron. PreBo¨tC neurons from Glra1sh/shmice have
GABAergic spIPSCs at a frequency of 0.760.18Hz (n12 from9mice),which is not different
from that observed in Glra1/ neurons (0.78 0.19 Hz, n 4 from 4mice).
Figure8. Glra1/andGlra1sh/shdonotdiffer inmotoneuronnumbers. Lumbar spinal cord
ofGlra1/ andGlra1 sh/sh at P28was cut in 12.5mslices, and the numbers ofmotoneurons
were counted. Spinal cord slices were stained with cresyl violet, and motoneurons were deter-
mined due to their large cell body (white arrowheads). A, Representative pictures from
Glra1/ and Glra1 sh/sh slices with large cell bodies of motoneurons. B, Quantitative analysis
of motoneuron numbers. The quantification was made using six to seven animals of each
genotype (Glra1/, n 6; Glra1 sh/sh, n 7). Error bars represent SDs.
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tion would be consistent with the significantly reduced IPSC fre-
quencies we observed in brainstem slice recordings.
Functional analysis in brainstem nuclei that are rich in glycin-
ergic synapses revealed largely reduced current amplitudes and
significantly lower frequencies of spontaneous and miniature
IPSCs in shaky mice, which are likely to be consequences of the
low numbers of postsynaptic functional receptors and enhanced
expression of functionally impaired presynaptic homomeric
GlyRs. As the reduced ligand potency of shakyGlyRs is still within
the range of glycine concentrations that can be achieved during
synaptic activation, the observed functional deficits must result
from disturbed translation of ligand binding into ion channel
opening (gating). Impaired gating was further confirmed by re-
duced efficacies of the partial agonists -alanine and taurine.
Moreover, residue Q177 normally undergoes H-bond formation
with the ligand-binding residue R65, which is disrupted by the
positively charged lysine. The positional change of the R65 side-
chain due to the introduction of additional positive charge from
K177would in turn destabilize the glycine-binding pocket, which
is in agreement with the observed decrease in glycine potency.
The importance of the 8–9 loop contribution to a hydrogen
bond network in bound and unbound receptor states has been
shown previously for 	2 GABAA and 5HT3A as well as nAChR
subunits (Nys et al., 2013).
The observed decrease in the decay time constant for the
1Q177K mutation, resulting in faster ion channel closure is sim-
ilar to spasmodicmice (Graham et al., 2006), arguing for a signif-
icant impact of ion channel decay mechanisms on the startle
phenotype and in the case of shaky a contribution to the lethality
in this mouse model. The functional analogy between spasmodic
and shakymice suggests a defect in the same signal transduction
pathway determined by coupling of ECD movements following
ligand binding to finally ion channel opening and closing (Du et
al., 2015). Functional synaptic 1Q177K GlyRs close much faster
Figure 9. GlyR 1 Q177K disrupts hydrogen bonding with the key ligand binding residue R65. A, Cryo-EM model 3JAE with the wild-type GlyR 1 (1 Q177, top right) and the modeled shaky
mutation (1 K177, bottom right). B, Top view of the homo-pentameric arrangement and position of Q177K. C, Glycine-binding pocket in the GlyR structure, where the glycine ligand is shown in
magenta, and surrounding residues are labeledappropriately.D, PositionofQ177basedon the cryo-EMmodel shown relative to thenewpositionof R65derivedupon flexible fitting into the cryo-EM
density using Flex-EM (Topf et al., 2008; Joseph et al., 2016). Interactions are indicated for Q177 with R65 from the glycine-binding pocket. E, The modeled Q177K substitution.
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than wild-type channels, implying a fast unbinding process of
the agonist. Since binding of glycine was only marginally affected
in spinal cord tissue, the functional defects of1Q177Kmust result
from downstream processes (e.g., fast transduction of ligand-
bound receptor into the closed conformation). These data are in
line with the recently proposed model of signal transduction for
GlyRs (Du et al., 2015; Morales-Perez et al., 2016; Nys et al.,
2016). Thus, the integrity of the 8–9 loop is a prerequisite for
conformational rearrangements and is crucial during gating pro-
cesses of the GlyR channel, which opens a novel window for
therapeutics, resulting in prolonged open times. Accordingly,
both the reduced synaptic integration and faster ion channel clo-
sure observed for GlyRs in shaky mice may also represent novel
pathogenicmechanisms for human startle diseasemutations. To-
gether, our data reveal that the 8–9 loop in the GlyR 1 ECD
is a key regulator of glycinergic signaling. Furthermore, shaky
represents the first in vivo mouse model demonstrating the in-
compatibility of a disrupted 8–9 loop with life.
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